Life Science Insights said it has published “Worldwide Therapeutic RNAi 2004-2014 Forecast and Analysis,” an analysis of the RNAi-based drugs market.
According to the company, the report includes an overview of RNAi technologies and a 10-year market forecast.
“The RNAi therapeutic market will grow to over $10 billion by 2014 if the first few RNAi therapies are successful in human clinical trials, which will start later this year,” Life Science Insights senior research editor Zachary Zimmerman said in a statement released this week.